Notably, for the Th1 cells, which execute anti-tumor immunity functions, multiple processes that promote their activities such as positive regulation of T-helper 1 cell cytokine production and positive regulation of T-helper 1 type immune response were positively regulated in the CKI-treated group. The gene discussed is CHKA; the disease is neoplasm.